Compare IQV & WTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IQV | WTW |
|---|---|---|
| Founded | 1982 | 1828 |
| Country | United States | United Kingdom |
| Employees | 93000 | 47000 |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.1B | 31.4B |
| IPO Year | 2013 | 2006 |
| Metric | IQV | WTW |
|---|---|---|
| Price | $238.70 | $344.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 14 |
| Target Price | $227.13 | ★ $366.29 |
| AVG Volume (30 Days) | ★ 1.4M | 561.0K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.32% |
| EPS Growth | 4.67 | ★ 1793.75 |
| EPS | 1.61 | ★ 5.53 |
| Revenue | ★ $9,739,000,000.00 | $9,708,000,000.00 |
| Revenue This Year | $6.77 | $9.46 |
| Revenue Next Year | $5.89 | $5.99 |
| P/E Ratio | $144.37 | ★ $61.48 |
| Revenue Growth | ★ 41.60 | N/A |
| 52 Week Low | $154.50 | $240.61 |
| 52 Week High | $251.36 | $352.79 |
| Indicator | IQV | WTW |
|---|---|---|
| Relative Strength Index (RSI) | 62.34 | 78.05 |
| Support Level | $218.57 | $311.61 |
| Resistance Level | $247.52 | $340.23 |
| Average True Range (ATR) | 7.83 | 8.79 |
| MACD | 0.63 | 3.23 |
| Stochastic Oscillator | 64.79 | 92.86 |
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Willis Towers Watson PLC is an advisory, broking, and solutions company that provides data-driven, insight-led solutions in the areas of people, risk, and capital. The company's segments include Health, Wealth & Career (HWC) and Risk & Broking (R&B). The HWC segment provides an array of advice, broking, solutions and technology for employee benefit plans, institutional investors, compensation and career programs, and employee experience overall. It focuses on four key areas: Health, Wealth, Career and Benefits Delivery & Outsourcing. The R&B segment provides risk advice, insurance brokerage and consulting services to clients ranging from small businesses to multinational corporations. Its R&B segment includes two businesses: Corporate Risk & Broking and Insurance Consulting and Technology.